Atlas Trials

VX-770 Expanded Access Program

Clinical trial NCT01381289 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT01381289
Sponsor
Vertex Pharmaceuticals Incorporated
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Cystic Fibrosis

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.